Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 2
Submit an article Journal homepage
201
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

A phase II clinical trial of lenalidomide intensification in patients with serologic/asymptomatic progression of multiple myeloma while on lenalidomide maintenance: a tri-state transplant consortium study

Hani HassounMemorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Ruthee BayerNorthwell Health Cancer Institute, Long Island Jewish Medical Center, North Shore University Hospital, the Monter Cancer Center, Lake Success, NY, USA; View further author information
,
Sean DevlinMemorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Theresa GentileUpstate University Hospital, Professor of Medicine, Syracuse, NY, USA; View further author information
,
Michael BeckerAdult Bone Marrow Transplant Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; View further author information
,
Kristen O’DweyerWilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA; View further author information
,
Martin LesserUniversity of Rochester Medical Center, Wilmot Cancer Institute, Rochester, NY, USA; View further author information
,
Heather LandauBiostatistics Unit, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, USA; ORCID Iconhttp://orcid.org/0000-0002-3152-1189View further author information
ORCID Icon,
David ChungAdult BMT Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA; View further author information
&
Sergio GiraltAdult BMT Service, Melvin Berlin Family Chair in Myeloma Research, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY, USACorrespondence[email protected]
View further author information
 show all
Pages 488-490 | Received 31 Aug 2019, Accepted 20 Sep 2019, Published online: 19 Jan 2020
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

Study was supported by an unrestricted research grant provided by Celgene corporation to the TriState Transplant Consortium. Dr Giralt has research support from CELGENE, Amgen, Takeda, Miltenyi, Novartis, Sanofi and has served as consultant to those companies. Other authors have provided conflict of interest disclosures.

Additional information

Funding

The Tri-State Transplant Consortium and this project were funded in part through a research grant obtained from CELGENE Corporation.

Log in via your institution

Access through your institution

Log in to Taylor & Francis Online

Restore content access

Restore content access for purchases made as guest
Purchase options * Save for later

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 1,065.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.